Rationale and design of the 500-patient, 3-year, and prospective Vigilant ObservatIon of GlIadeL WAfer ImplaNT registry

Implantation of biodegradable wafers impregnated with carmustine (BCNU) is one of the few chemotherapeutic modalities that have been evaluated in Phase III trials and approved by the US FDA for treatment of newly diagnosed high-grade glioma and recurrent glioblastoma. Enrolling up to 500 patients fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lillehei, Kevin O, Kalkanis, Steven N, Liau, Linda M, Mydland, Dellann Elliott, Olson, Jeffrey, Paleologos, Nina A, Ryken, Timothy, Johnson, Tania, Scullin, Evan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2017
Materias:
Clinical Trial Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977275/
https://www.ncbi.nlm.nih.gov/pubmed/29206049
http://dx.doi.org/10.2217/cns-2017-0036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977275/
https://www.ncbi.nlm.nih.gov/pubmed/29206049
http://dx.doi.org/10.2217/cns-2017-0036

Ejemplares similares